Healthtech Startup Doccla Raises $46 Million to Expand in Europe

The UK-based healthtech startup Doccla recently raised £35m—$46 million—during a series B led by the European capital firm Lakestar. In the round, current and new investors joined and will now allow the startup to expand.

Doccla describes itself as a “Europe’s leading virtual hospital” and has developed a technology to help doctors manage patients remotely and for patients to easily access medical attention through an app.

“Doccla was founded to provide hospital-level care and support at home for multiple patient profiles across the acuity spectrum: enabling the early discharge of patients, as well as ensuring that for those with chronic care needs, hospital admission might be avoided in the first place,” said Martin Ratz, Doccla founder, to TechEU. “Technology-enabled virtual wards deliver great benefits for patients, who can recover at home, while freeing up resources for healthcare providers.”

According to TechEU, with the new investments, the company—based in London—will consolidate its presence in the United Kingdom and Ireland, and expand its services in France, Germany, Austria, and Switzerland.

As disclosed on its official website, Doccla already has a presence across more than 10 countries in the European Union, and monitors millions of users every month. According to the data features, they supervise 4 million patients a day.

“In less than five years Doccla has gone from a research project to establishing itself as the market leader in the UK. We are confident they will not just maintain that position but successfully launch in new markets, whilst diversifying their services,” said Oliver Heimes, Lakestar Partner and new Doccla board member, “Remote patient care delivers proven results and is ushering in new standards in the healthcare systems globally.”

Other UK-based tech startups have been developing new products and expanding across the world. London-based nutrition startup Zoe recently raised $15 million in a series B to expand to the United States.